DK0843821T3 - Fremgangsmåde til karakterisering af glycosyleringen af glycoproteiner samt til in vitro-bestemmelse af biotilgængeligheden af glycoproteiner - Google Patents

Fremgangsmåde til karakterisering af glycosyleringen af glycoproteiner samt til in vitro-bestemmelse af biotilgængeligheden af glycoproteiner

Info

Publication number
DK0843821T3
DK0843821T3 DK96917465T DK96917465T DK0843821T3 DK 0843821 T3 DK0843821 T3 DK 0843821T3 DK 96917465 T DK96917465 T DK 96917465T DK 96917465 T DK96917465 T DK 96917465T DK 0843821 T3 DK0843821 T3 DK 0843821T3
Authority
DK
Denmark
Prior art keywords
glycoproteins
glycosylation
bioavailability
characterizing
pct
Prior art date
Application number
DK96917465T
Other languages
English (en)
Inventor
Peter Hermentin
Reinhild Witzel
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK0843821T3 publication Critical patent/DK0843821T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK96917465T 1995-07-26 1996-05-30 Fremgangsmåde til karakterisering af glycosyleringen af glycoproteiner samt til in vitro-bestemmelse af biotilgængeligheden af glycoproteiner DK0843821T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19527054A DE19527054A1 (de) 1995-07-26 1995-07-26 Verfahren zur Charakterisierung der Glycosylierung von Glycoproteinen sowie zur in-vitro Bestimmung der Bioverfügbarkeit von Glycoproteinen
PCT/EP1996/002319 WO1997005490A1 (de) 1995-07-26 1996-05-30 Verfahren zur charakterisierung der glycosylierung von glycoproteinen sowie zur in-vitro bestimmung der bioverfügbarkeit von glycoproteinen

Publications (1)

Publication Number Publication Date
DK0843821T3 true DK0843821T3 (da) 2002-01-28

Family

ID=7767674

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96917465T DK0843821T3 (da) 1995-07-26 1996-05-30 Fremgangsmåde til karakterisering af glycosyleringen af glycoproteiner samt til in vitro-bestemmelse af biotilgængeligheden af glycoproteiner

Country Status (13)

Country Link
US (1) US6096555A (da)
EP (1) EP0843821B1 (da)
JP (1) JP3631495B2 (da)
KR (1) KR19990035943A (da)
AT (1) ATE206524T1 (da)
AU (1) AU6003296A (da)
CA (1) CA2227743C (da)
DE (2) DE19527054A1 (da)
DK (1) DK0843821T3 (da)
ES (1) ES2162652T3 (da)
NO (1) NO980276D0 (da)
PT (1) PT843821E (da)
WO (1) WO1997005490A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020144310A1 (en) * 2000-01-28 2002-10-03 Lightfoot David A. Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same
US20030096281A1 (en) * 2001-09-14 2003-05-22 Ganesh Venkataraman Methods of making glycomolecules with enhanced activities and uses thereof
WO2003054172A2 (en) * 2002-01-17 2003-07-03 Lonza Biologics Plc. Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium
EP1587408A4 (en) * 2002-12-20 2007-09-05 Momenta Pharmaceuticals Inc GLYCAN MARKER FOR DIAGNOSIS AND MONITORING OF DISEASES
JP4077339B2 (ja) * 2003-03-06 2008-04-16 独立行政法人科学技術振興機構 高等植物の糖リン酸の網羅的分析法
DE102005050580A1 (de) 2005-10-21 2007-04-26 Siegfried Biologics Gmbh Verfahren zur Charakterisierung der Qualität von Sialoglycoproteinen über eine Isoformenzahl I und dessen Verwendung
CN102239173A (zh) * 2008-12-19 2011-11-09 动量制药公司 与修饰的聚糖相关的方法
MX2012011648A (es) 2010-04-07 2012-11-29 Momenta Pharmaceuticals Inc Glicanos de alta manosa.
US9170249B2 (en) 2011-03-12 2015-10-27 Momenta Pharmaceuticals, Inc. N-acetylhexosamine-containing N-glycans in glycoprotein products
US20160145589A1 (en) 2011-06-24 2016-05-26 Green Cross Corporation Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
EP2856159A4 (en) 2012-06-01 2016-04-13 Momenta Pharmaceuticals Inc METHODS RELATING TO DENOSUMAB
US9150841B2 (en) 2012-06-29 2015-10-06 Shire Human Genetic Therapies, Inc. Cells for producing recombinant iduronate-2-sulfatase
KR101380740B1 (ko) * 2012-06-29 2014-04-11 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 이듀로네이트-2-설파타제의 정제
US10450361B2 (en) 2013-03-15 2019-10-22 Momenta Pharmaceuticals, Inc. Methods related to CTLA4-Fc fusion proteins
US10464996B2 (en) 2013-05-13 2019-11-05 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
EP3058084A4 (en) 2013-10-16 2017-07-05 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins

Also Published As

Publication number Publication date
KR19990035943A (ko) 1999-05-25
EP0843821A1 (de) 1998-05-27
EP0843821B1 (de) 2001-10-04
NO980276L (no) 1998-01-21
NO980276D0 (no) 1998-01-21
WO1997005490A1 (de) 1997-02-13
US6096555A (en) 2000-08-01
ATE206524T1 (de) 2001-10-15
JP3631495B2 (ja) 2005-03-23
MX9800690A (es) 1998-09-30
DE19527054A1 (de) 1997-01-30
AU6003296A (en) 1997-02-26
PT843821E (pt) 2002-03-28
ES2162652T3 (es) 2002-01-01
JP2000503109A (ja) 2000-03-14
CA2227743C (en) 2008-01-29
DE59607840D1 (de) 2001-11-08
CA2227743A1 (en) 1997-02-13

Similar Documents

Publication Publication Date Title
DK0843821T3 (da) Fremgangsmåde til karakterisering af glycosyleringen af glycoproteiner samt til in vitro-bestemmelse af biotilgængeligheden af glycoproteiner
TR199600357A2 (tr) Rekombinant simanlik (Ob) proteinleri.
DE69621831D1 (de) Piperazinderivative als tachykinin antagonisten
DE69636854D1 (de) Zugriffs- und lieferungssystem für on-line/informationsdienste
TR199600084A2 (tr) Sismanlamaya karsi proteinler.
HK1036475A1 (en) Erythropoietin analog-human serum albumin fusion protein
DE69634950D1 (de) Identifizierung von anwendungsfähigkeiten für telekonferenzverbindungen
DE69612434T2 (de) Postverarbeitungssystem
GB2363660A (en) A method and system for providing data to a user based on a user's query
DK0741870T3 (da) Fremgangsmåde til kvantificering af LBP i kropsvæsker
WO1999020747A3 (en) HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS
DE19880053D2 (de) Komponentenerkennungs- und Verwaltungssystem für optische Netzwerke
EP1029916A4 (en) HUMAN LYSOPHOSPHATIDE ACID RECEPTOR AND USE OF SAID RECEPTOR
WO2001002896A8 (en) System, apparatus, and method for reducing birefringence
AU3186397A (en) Prion protein binding proteins and uses thereof
IL122606A0 (en) (S)-hydroxy-nitrile-lyase
TW350032B (en) Method for removing hard coat film from plastic lens
DE69510958D1 (de) Microemulsionspolymerisation-systeme für tetrafluorethylen
DE59608073D1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
DK0843658T3 (da) Endoparasiticide midler på grundlag af didepsipeptider, nye didepsipeptider samt fremgangsmåder til deres fremstilling
AU6764196A (en) Methods and antibodies for detecting creatine kinase
WO1999021994A3 (en) Human vesicle membrane protein-like proteins
NZ334744A (en) Method for determining expression of aberrant forms of APC protein
NO982377D0 (no) Chip-kort med multifunksjonschip, anlegg samt fremgangsmÕte for anvendelse av samme
WO2002057874A3 (en) System and process for routing information in a data processing system